These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34923063)

  • 21. Impact of COAPT trial exclusion criteria in real-world patients undergoing transcatheter mitral valve repair.
    Iliadis C; Metze C; Körber MI; Baldus S; Pfister R
    Int J Cardiol; 2020 Oct; 316():189-194. PubMed ID: 32470537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial.
    Lindman BR; Asch FM; Grayburn PA; Mack MJ; Bax JJ; Gonzales H; Goel K; Barker CM; Zalawadiya SK; Zhou Z; Alu MC; Weissman NJ; Abraham WT; Lindenfeld J; Stone GW
    JACC Cardiovasc Interv; 2023 May; 16(10):1160-1172. PubMed ID: 37225286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
    Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
    Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score.
    Adamo M; Rubbio AP; Zaccone G; Pighi M; Massussi M; Tomasoni D; Pancaldi E; Testa L; Tusa MB; De Marco F; Giannini C; Grasso C; De Felice F; Denti P; Godino C; Mongiardo A; Crimi G; Villa E; Monteforte I; Citro R; Giordano A; Bartorelli AL; Petronio AS; Chizzola G; Tarantini G; Tamburino C; Bedogni F; Metra M
    EuroIntervention; 2023 Apr; 18(17):1408-1417. PubMed ID: 36809256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regurgitant volume to LA volume ratio in patients with secondary MR: the COAPT trial.
    Coisne A; Scotti A; Granada JF; Grayburn PA; Mack MJ; Cohen DJ; Kar S; Lim DS; Lindenfeld J; Bax J; Kotinkaduwa LN; Redfors B; Weissman NJ; Asch FM; Stone GW
    Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):616-625. PubMed ID: 38060997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.
    Anker SD; Friede T; von Bardeleben RS; Butler J; Khan MS; Diek M; Heinrich J; Geyer M; Placzek M; Ferrari R; Abraham WT; Alfieri O; Auricchio A; Bayes-Genis A; Cleland JGF; Filippatos G; Gustafsson F; Haverkamp W; Kelm M; Kuck KH; Landmesser U; Maggioni AP; Metra M; Ninios V; Petrie MC; Rassaf T; Ruschitzka F; Schäfer U; Schulze PC; Spargias K; Vahanian A; Zamorano JL; Zeiher A; Karakas M; Koehler F; Lainscak M; Öner A; Mezilis N; Theofilogiannakos EK; Ninios I; Chrissoheris M; Kourkoveli P; Papadopoulos K; Smolka G; Wojakowski W; Reczuch K; Pinto FJ; Zmudka K; Kalarus Z; Adamo M; Santiago-Vacas E; Ruf TF; Gross M; Tongers J; Hasenfuß G; Schillinger W; Ponikowski P
    Eur J Heart Fail; 2024 Jul; 26(7):1608-1615. PubMed ID: 38847420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge-to-edge repair: Results from the EXPAND study.
    Kessler M; Rottbauer W; von Bardeleben RS; Grasso C; Lurz P; Mahoney P; Price M; Williams M; Denti P; Estevez-Loureiro R; Kar S; Maisano F
    Eur J Heart Fail; 2024 Jul; 26(7):1495-1503. PubMed ID: 38726573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Brugger N; Kassar M; Siontis GCM; Widmer S; Okuno T; Winkel MG; Corpataux N; Gräni C; Büllesfeld L; Hunziker L; Pilgrim T; Windecker S; Praz F
    Catheter Cardiovasc Interv; 2021 Dec; 98(7):1404-1412. PubMed ID: 34406713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With Functional Mitral Regurgitation.
    Chhatriwalla AK; Cohen DJ; Vemulapalli S; Vekstein A; Huded CP; Gallup D; Kosinski AS; Brothers L; Lindenfeld J; Stone GW; Sorajja P
    J Am Coll Cardiol; 2024 Jan; 83(4):488-499. PubMed ID: 38267110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrovascular Events After Transcatheter Edge-to-Edge Repair and Guideline-Directed Medical Therapy in the COAPT Trial.
    Vincent F; Redfors B; Kotinkaduwa LN; Kar S; Lim DS; Mishell JM; Whisenant BK; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2023 Jun; 16(12):1448-1459. PubMed ID: 37380226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, Predictors, and Outcomes Associated With Worsening Renal Function in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.
    Kong J; Zaroff JG; Ambrosy AP; Fitzpatrick JK; Ku IA; Mishell JM; Kotinkaduwa LN; Redfors B; Beohar N; Ailawadi G; Lindenfeld J; Abraham WT; Mack MJ; Kar S; Lim DS; Whisenant BK; Stone GW
    J Am Heart Assoc; 2023 Jul; 12(14):e029504. PubMed ID: 37421291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT Trial.
    Halaby R; Herrmann HC; Gertz ZM; Lim S; Kar S; Lindenfeld J; Abraham WT; Grayburn PA; Naidu S; Asch FM; Weissman NJ; Zhang Y; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2021 Apr; 14(8):879-889. PubMed ID: 33888233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staging Heart Failure Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.
    Stolz L; Doldi PM; Orban M; Karam N; Puscas T; Wild MG; Popescu A; von Bardeleben RS; Iliadis C; Baldus S; Adamo M; Thiele H; Besler C; Unterhuber M; Ruf T; Pfister R; Higuchi S; Koell B; Giannini C; Petronio A; Kassar M; Weckbach LT; Butter C; Stocker TJ; Neuss M; Melica B; Braun D; Windecker S; Massberg S; Praz F; Näbauer M; Kalbacher D; Lurz P; Metra M; Bax JJ; Hausleiter J;
    JACC Cardiovasc Interv; 2023 Jan; 16(2):140-151. PubMed ID: 36697148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial.
    Giustino G; Lindenfeld J; Abraham WT; Kar S; Lim DS; Grayburn PA; Kapadia SR; Cohen DJ; Kotinkaduwa LN; Weissman NJ; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2020 Oct; 13(20):2317-2328. PubMed ID: 33092705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary Outcomes Following Transcatheter Edge-to-Edge Repair: 1-Year Results From the EXPAND Study.
    Kar S; von Bardeleben RS; Rottbauer W; Mahoney P; Price MJ; Grasso C; Williams M; Lurz P; Ahmed M; Hausleiter J; Chehab B; Zamorano JL; Asch FM; Maisano F
    JACC Cardiovasc Interv; 2023 Mar; 16(5):589-602. PubMed ID: 36922046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres.
    Kitamura M; Kaneko H; Schlüter M; Schewel D; Schmidt T; Alessandrini H; Kreidel F; Neuss M; Butter C; Kuck KH; Frerker C
    Clin Res Cardiol; 2019 Mar; 108(3):264-272. PubMed ID: 30097683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPT trial.
    Feng KY; Ambrosy AP; Zhou Z; Li D; Kong J; Zaroff JG; Mishell JM; Ku IA; Scotti A; Coisne A; Redfors B; Mack MJ; Abraham WT; Lindenfeld J; Stone GW;
    Eur J Heart Fail; 2023 Apr; 25(4):553-561. PubMed ID: 36823954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitral Surgery After Transcatheter Edge-to-Edge Repair: Society of Thoracic Surgeons Database Analysis.
    Chikwe J; O'Gara P; Fremes S; Sundt TM; Habib RH; Gammie J; Gaudino M; Badhwar V; Gillinov M; Acker M; Rowe G; Gill G; Goldstone AB; Schwann T; Gelijns A; Trento A; Mack M; Adams DH
    J Am Coll Cardiol; 2021 Jul; 78(1):1-9. PubMed ID: 33945832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal Outcomes Following Transcatheter Mitral Valve Repair - Analysis of COAPT Trial Data.
    Shekhar S; Kansara T; Morozowich ST; Mohananey D; Agrawal A; Narasimhan S; Nelson JA; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2023 Oct; 37(10):2119-2124. PubMed ID: 37210324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low body mass index and risk of mortality after mitral transcatheter edge-to-edge repair procedure: The "obesity paradox".
    Carter-Storch R; Veien KT; Mogensen NSB; Banke A; Tofte-Hansen EU; Ali M; Laursen K; Dahl JS
    Catheter Cardiovasc Interv; 2024 Aug; 104(2):401-407. PubMed ID: 38819910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.